Clinical Trials Directory

Trials / Unknown

UnknownNCT03480308

Effect of Addition of Fentanyl or Dexamethasone or Both to Bupivacaine in Paravertebral Block for Patients Undergoing Major Breast Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery.

Detailed description

This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery. Patients will receive ultrasound guided paravertebral block and stratified into 3 groups according to medication used : Group 1 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg Group 2 : bupivacaine (0.5%) 20 ml , dexamethasone 4 mg Group 2 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg , dexamethasone 4 mg

Conditions

Interventions

TypeNameDescription
DRUGFentanylPatients will receive bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg in paravertebral block
DRUGDexamethasonePatients will receive bupivacaine (0.5%) 20 ml , Dexamethasone 4mg in paravertebral block
DRUGBupivacaineBupivacaine

Timeline

Start date
2018-04-01
Primary completion
2019-04-01
Completion
2021-03-30
First posted
2018-03-29
Last updated
2021-02-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03480308. Inclusion in this directory is not an endorsement.